iRhythm Technologies, Inc. (IRTC)
$
140.5
-1.74 (-1.24%)
Key metrics
Financial statements
Free cash flow per share
0.4414
Market cap
4.5 Billion
Price to sales ratio
7.2141
Debt to equity
8.4867
Current ratio
5.7121
Income quality
-0.4834
Average inventory
14.2 Million
ROE
-1.1284
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
iRhythm Technologies, Inc. is a digital healthcare company that focuses on providing ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. The company incurred an interest expense of $12,821,000.00 reflecting its debt servicing obligations. Its operating income ratio is -0.20 indicating the company's operational profitability margin. Additionally, the earnings per share (EPS) is reported at -$3.63 which signifies the company's profitability on a per-share basis. The company also incurred an income tax expense of $565,000.00 indicating its tax obligations. With a weighted average number of shares outstanding of 31,196,000.00 the data highlights the company's shareholder base. iRhythm offers the Zio service, an advanced ambulatory cardiac monitoring solution that integrates a wire-free, patch-based, and wearable biosensor with a sophisticated cloud-based data analytic platform, ultimately assisting physicians in monitoring patients and diagnosing arrhythmias. The Zio XT and AT monitors, which are single-use, wire-free, and wearable patch-based biosensors, effectively record patients' heartbeats and ECG data. Moreover, the company collaborates with Verily Life Sciences LLC in a development agreement aimed at creating next-generation products for atrial fibrillation screening, detection, or monitoring. Founded in 2006 and headquartered in San Francisco, California, iRhythm stands out as a notable entity in healthcare technology. The stock is reasonably priced at $142.24 appealing to a broad range of investors. With an average trading volume of 480,134.00 the stock indicates moderate liquidity, which is a positive trait for prospective shareholders. With a mid-range market capitalization of $4,485,504,650.00 the company is recognized as a steady performer within its domain. As a key player in the Medical - Devices industry, iRhythm contributes significantly to the overall market landscape. Furthermore, it belongs to the Healthcare sector, driving innovation and growth while enhancing the quality of care through its advanced monitoring solutions.
Is iRhythm Technologies, Inc. (IRTC) a good investment?
Investing in iRhythm Technologies, Inc. (IRTC) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as D+, with a Bearish outlook. Always conduct your own research before investing.
What is iRhythm Technologies, Inc. (IRTC)'s stock forecast?
Analysts predict iRhythm Technologies, Inc. stock to fluctuate between $55.92 (low) and $146.58 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is iRhythm Technologies, Inc.'s market capitalization?
As of 2025-05-30, iRhythm Technologies, Inc.'s market cap is $4,485,504,650, based on 31,925,300 outstanding shares.
How does iRhythm Technologies, Inc. compare to competitors like Eli Lilly & Co.?
Compared to Eli Lilly & Co., iRhythm Technologies, Inc. has a Lower Market-Cap, indicating a difference in performance.
How can I buy iRhythm Technologies, Inc. (IRTC) stock?
To buy iRhythm Technologies, Inc. (IRTC) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for IRTC. Place an order (Market, Limit, etc.).
What is the best time to invest in iRhythm Technologies, Inc.?
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
How did iRhythm Technologies, Inc. perform in the last earnings report?
Revenue: $591,839,000 | EPS: -$3.63 | Growth: -10.15%.
Where can I find iRhythm Technologies, Inc.'s investor relations reports?
Visit https://www.irhythmtech.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for iRhythm Technologies, Inc.?
You can explore historical data from here
What is the all-time high and low for iRhythm Technologies, Inc. stock?
All-time high: $253.73 (2021-01-29) | All-time low: $41.66 (2021-08-19).
What are the key trends affecting iRhythm Technologies, Inc. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
globenewswire.com
SAN FRANCISCO, May 21, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that its management team is scheduled to present at the following investor conferences.
benzinga.com
iRhythm Technologies Inc IRTC on Thursday reported first quarter 2025 revenue of $158.7 million, up 20.3% year over year, beating the consensus of $153.38 million.
seekingalpha.com
iRhythm Technologies, Inc. (NASDAQ:IRTC ) Q1 2025 Earnings Conference Call May 1, 2025 4:30 PM ET Company Participants Stephanie Zhadkevich - Director, IR Quentin Blackford - President & CEO Daniel Wilson - CFO Conference Call Participants Allen Gong - JPMorgan Kallum Titchmarsh - Morgan Stanley Macauley Kilbane - William Blair Nathan Treybeck - Wells Fargo David Rescott - Baird David Saxon - Needham & Company Suraj Kalia - Oppenheimer Jon Young - Canaccord Genuity Sam Eiber - BTIG Richard Newitter - Truist Operator Good afternoon. Thank you for attending the iRhythm Technologies, Inc. First Quarter 2025 Earnings Conference Call.
globenewswire.com
SAN FRANCISCO, April 17, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the first quarter 2025 after the close of trading on Thursday, May 1, 2025. The company's management team will host a corresponding conference call beginning at 1:30 p.m.
globenewswire.com
SAN FRANCISCO, April 16, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc . (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced that it has published its 2024 Corporate Sustainability Report , highlighting the company's efforts to build a sustainable and inclusive future.
zacks.com
iRhythm Technologies (IRTC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
seekingalpha.com
iRhythm Technologies, Inc. (NASDAQ:IRTC ) Q4 2024 Earnings Conference Call February 20, 2025 4:30 PM ET Company Participants Stephanie Zhadkevich - Director, IR Quentin Blackford - President & CEO Daniel Wilson - CFO Conference Call Participants Macauley Kilbane - William Blair Lilia-Celine Lozada - JPMorgan Kallum Titchmarsh - Morgan Stanley Nathan Treybeck - Wells Fargo David Roman - Goldman Sachs Sam Eiber - BTIG Jon Young - Canaccord Genuity David Rescott - Baird Suraj Kalia - Oppenheimer Felipe Lamar - Truist Paige Chamberlain - Wolfe Research Operator Good afternoon. Thank you for attending today's iRhythm Technologies Q4 2024 Earnings Conference Call.
zacks.com
IRhythm Technologies (IRTC) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.30 per share. This compares to loss of $1.26 per share a year ago.
See all news
